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Abstract
The bactericidal function of macrophages against pneumococci is enhanced by their apoptotic demise, which is controlled
by the anti-apoptotic protein Mcl-1. Here, we show that lysosomal membrane permeabilization (LMP) and cytosolic
translocation of activated cathepsin D occur prior to activation of a mitochondrial pathway of macrophage apoptosis.
Pharmacological inhibition or knockout of cathepsin D during pneumococcal infection blocked macrophage apoptosis. As a
result of cathepsin D activation, Mcl-1 interacted with its ubiquitin ligase Mule and expression declined. Inhibition of
cathepsin D had no effect on early bacterial killing but inhibited the late phase of apoptosis-associated killing of
pneumococci in vitro. Mice bearing a cathepsin D
2/2 hematopoietic system demonstrated reduced macrophage apoptosis
in vivo, with decreased clearance of pneumococci and enhanced recruitment of neutrophils to control pulmonary infection.
These findings establish an unexpected role for a cathepsin D-mediated lysosomal pathway of apoptosis in pulmonary host
defense and underscore the importance of apoptosis-associated microbial killing to macrophage function.
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Introduction
Macrophages are essential for the maintenance of tissue
homeostasis, as they remove dying and dead cells [1]. Macro-
phages must also coordinate the innate response to microorgan-
isms that penetrate sterile environments such as the lower
respiratory tract [2,3]. To accommodate their opposing roles in
long-term tissue homeostasis and short-term immune responses,
tissue macrophages, such as alveolar macrophages, are long-lived
in the basal state [4,5], yet can activate a variety of death pathways
upon pathogen encounter [6].
Streptococcus pneumoniae, the pneumococcus, is the most prevalent
cause of community-acquired pneumonia [7]. During the initial
stages of pneumococcal infection, macrophages are largely
responsible for bacterial clearance and determine the initiation
as well as the later resolution of the inflammatory response [8,9].
Macrophage function is regulated by induction of apoptosis during
pneumococcal infection [8,10]. The shift from apoptosis resistance
is determined by the decline in abundance of the anti-apoptotic
protein Mcl-1 [11,12]. Mcl-1 expression is regulated by transcrip-
tion and translation [13]. Moreover, Mcl-1 has a short half-life, the
result of its proteasomal degradation after ubiquitination [14,15],
which is mediated by the ubiquitin E3 ligase Mule (Mcl-1
ubiquitin ligase E3 (Mule)/ARF-BP1) [16]. Mcl-1 can also be
degraded by caspases [17] and potentially by other proteases [16].
During pneumococcal infection Mcl-1 downregulation is regulated
post-transcriptionally with evidence of enhanced ubiquitination
[12].
Induction of macrophage apoptosis by pneumococcal infection
requires internalization and killing of bacteria, an event localized
to the phagolysosome [10,18,19]. Lysosomal membrane permea-
bilization (LMP) can trigger either apoptosis (through activation of
lysosomal proteases of the cathepsin family) [20] or non-apoptotic
cell death with features of necrosis [21], especially when LMP is
extensive [22]. Cathepsins can cleave Bcl-2 family members to
trigger the mitochondrial pathway of apoptosis [23,24,25,26] or
may directly activate caspases [27]. Despite the importance of
lysosomes in antibacterial host defense, LMP has not yet been
investigated in the host-pathogen relationship or linked to innate
immune responses [22].
Here, we demonstrate that pneumococci trigger LMP and
activation of cathepsin D in macrophages. Activation of cathepsin
D enhances the interaction of Mcl-1 with its ubiquitin ligase,
resulting in its destruction. The induction of macrophage apoptosis
that results from cathepsin D activation provides a late increment
to bacterial killing. These results indicate that cathepsin D plays a
PLoS Pathogens | www.plospathogens.org 1 January 2011 | Volume 7 | Issue 1 | e1001262major pathophysiological role in the inter-relationship between
intracellular pneumococci and macrophages that defines innate
immune competence.
Results
Pneumococcal infection triggers lysosomal membrane
permeabilization (LMP)
Since the apoptotic program can be initiated by several
organelles including lysosomes [20], we investigated whether
bacterial killing in phagolysosomes was associated with signs of
LMP, an early feature of some apoptotic pathways. We confirmed
internalization of pneumococci in the differentiated THP-1
macrophage-like cell line (Figure S1), which we have recently
shown has a similar susceptibility to apoptosis and produces
similar innate responses to monocyte-derived macrophages
(MDM) [28]. As early as 10 h after infection an increased
percentage of cells exposed to pneumococci exhibited reduced
incorporation of the acidophilic dye acridine orange, indicating
loss of lysosomal acidification (LLA) (Figure 1A,C). Simultaneous
staining of a separate aliquot of cells from the same cultures
demonstrated that LLA occurred prior to the dissipation of the
inner mitochondrial transmembrane potential (DYm)
(Figure 1B,D). We have previously demonstrated that macrophage
apoptosis during pneumococcal infection is caspase-dependent
[18] and caspase activation has been reported to trigger LMP [29].
Nonetheless, addition of the broad-spectrum caspase inhibitor
zVADfmk failed to prevent LLA, indicating that LLA is not a late
consequence of apoptosis (Figure 1E). An alternative marker of
lysosomal integrity, pepstatin A-BODIPY FL, whose binding to
the lysosomal protease cathepsin D is pH-dependent [30], failed to
stain the lysosomes from the infected macrophage-like cell line,
while control cells exhibited a punctate lysosomal staining pattern
under the same experimental conditions (Figure 1F). The
lysosomal nature of staining was confirmed since organelle
purification using discontinuous sucrose gradients confirmed initial
cathepsin D localization in fractions stained with lysosomal
markers 6 h after exposure to pneumococci (Figure S2). These
results indicate that pneumococcal infections cause impairment of
lysosomal acidification and/or LMP. Subcellular fractionation
followed by immunoblotting revealed cytosolic translocation of
cathepsins D and B in the infected macrophage-like cell line, while
the amount of cathepsin D and B contained in the lysosomal
fraction declined at the later time point of 16 h after exposure to
pneumococci (Figure 1G). Imaging of individual cells, as shown in
Figure 1F, confirmed that loss of LLA/LMP was occurring in
single cells, not just at the level of the total cell population, and that
LLA/LMP preceded DYm and nuclear fragmentation (data not
shown). The pneumococcal toxin pneumolysin was required for
LLA since a pneumolysin deficient pneumococcal strain, PLY-
STOP, did not induce LLA (Figure 1H), despite being internalized
to a similar extent to the wild-type strain (Figure S1). Moreover
complementation of this mutant with pneumolysin restored LLA,
DYm and cytolytic activity (Figure S3A–C). Altogether, these
results indicate that pneumococci trigger LMP.
Pneumococcal infection is associated with activation of
cathepsin D
Cathepsin D, a lysosomal protease, can induce apoptosis when
it is activated and released into the cytosol [22]. As shown in
Figure 2A, cathepsin D, the most abundant cathepsin in
differentiated macrophages [31], underwent proteolytic matura-
tion in phagolysosomes following pneumococcal infection, as
evidenced by detection of the heavy chain form of active cathepsin
D. We also confirmed that the organelles isolated on a sucrose
gradient were phagolysosomes by identifying markers of phago-
lysosomes such as LAMP-1, rab-5 and -7 (Figure S2). A functional
assay, based on the proteolytic processing of a fluorogenic
cathepsin D substrate, confirmed that pneumococcal infection of
macrophages resulted in enhanced cathepsin D activity as early as
8 h post-infection (Figure 2B), provided that the pneumococci
expressed the toxin pneumolysin (Figure 2C). The pneumolysin
deficient pneumococcal strain, PLYSTOP, stimulated significantly
less cathepsin D activation than the isogenic wild-type strain from
which it was derived. Reintroduction of pneumolysin into the
PLYSTOP mutant restored activation of cathepsin D to a level
comparable to the wild-type strain (Figure S3D). The cathepsin D
activity was not significantly enhanced after phagocytosis of latex
beads or of another Gram-positive bacterium Staphylococcus aureus,
which is readily internalized [32]. Cathepsin D activity is optimal
at acidic pH, and bacterial phagocytosis can result in cytosolic
acidification [33,34]. We found the cytosolic pH was acidified
following pneumococcal infection (Figure 2D–E). The reduction in
cytosolic pH occurred with the same kinetics as LLA (Figure 1C),
and before dissipation of DYm (Figure 1D). A cathepsin D
inhibitor, pepstatin A, blocked cathepsin D activation (Figure S3D)
but failed to reverse the reduction in cytosolic pH of cells exposed
to pneumococci (Figure 2E), indicating that the cytosolic
acidification was not a consequence of cathepsin D activation.
Altogether our data suggest LMP allows release of active cathepsin
D into an acidified cytosol.
Cathepsin D activation is required for macrophage
apoptosis during pneumococcal infection
A range of inhibitors active against cathepsins B, D and L, the
most abundant cathepsins in differentiated macrophages [35],
were screened for their capacity to prevent loss of DYm, one of the
first signs of irreversible cell death. Only inhibitors with activity
Author Summary
Tissue macrophages frequently undergo a program of cell
death, termed apoptosis, following sustained ingestion
and killing of bacteria. In macrophages, induction of
apoptosis enhances bacterial killing when macrophages’
initial killing capacity is exhausted. We have investigated
the mechanism of apoptosis in macrophages exposed to
pneumococci, the commonest cause of bacterial pneumo-
nia. We show that the cell structure containing ingested
bacteria, the phagolysosome, becomes permeabilized
early in the death process. Pneumococcal exposure
activates a phagolysosomal enzyme, cathepsin D, which
induces apoptosis. Cathepsin D activation is required for
permeabilization of mitochondria, an organelle implicated
in apoptosis induction. Cathepsin D reduces levels of a
negative regulator of apoptosis in macrophages, Mcl-1, by
enhancing its association with an enzyme, which mediates
its degradation. The importance of these findings was
confirmed in a bone marrow transplant model in which
mice either received bone marrow from mice containing or
lacking the cathepsin D gene. This model showed that
reduced apoptosis of alveolar macrophages occurred
when cathepsin D was lacking, and that this impaired
clearance of pneumococci in the mouse lung. We conclude
that during bacterial challenge, lysosomal permeabiliza-
tion and cathepsin D activation triggers a novel death
pathway, in a timely fashion, linking bacterial killing to
apoptosis induction.
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PLoS Pathogens | www.plospathogens.org 2 January 2011 | Volume 7 | Issue 1 | e1001262Figure 1. Differentiated THP-1 cells infected with pneumococci exhibit loss of lysosomal acidification and cytosolic translocation of
cathepsin D. Differentiated THP-1 cells were infected with pneumococci (D39) and stained with (A, C) acridine orange (AO) and (B, D) JC-1 at the
designated times post infection. (A–B) Representative histograms from one infection and (C–D) graphs summarizing loss of lysosomal acidification
(LLA) and inner mitochondrial transmembrane potential (DYm) in three separate experiments are shown, *=p,0.05, **=p,0.01, one way ANOVA
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able to prevent the dissipation of DYm (Figure S4A). Pepstatin A
inhibited loss of DYm (Figure 3A) and prevented the mitochondrial
cytochrome c release induced by pneumococcal infection
(Figure 3B). Pepstatin A also inhibited other signs of apoptosis
including caspase 3/7 activation, chromatin condensation and
nuclear fragmentation (Figure 3C–D). The anti-apoptotic activity
of pepstatin was shared with other cathepsin D inhibitors, such as
MPC6 (Figure 3A and 3D) and DAME (Figure S4B). Pepstatin A
inhibited apoptosis in the macrophage-like cell line, and the
residual apoptosis was further blocked by an anti-oxidant and an
inhibitor of inducible nitric oxide synthase (Figure S5). The key
findings of cathepsin D activation, LLA and reduced apoptosis
(dissipation of DYm and nuclear fragmentation) with pepstatin A
treatment, following pneumococcal infection, were replicated in
monocyte-derived macrophages (MDM; Figure S6). These results
suggest cathepsin D plays a critical role in macrophage apoptosis
during pneumococcal infection, downstream of LMP but up-
stream of the mitochondrial phase of the cell death pathway.
Cathepsin D-deficient macrophages are resistant to
apoptosis during pneumococcal infection
To exclude off-target effects of pharmacological inhibitors and
since cathepsin D is the major aspartic protease inhibited by
pepstatin A, but other aspartic proteases could also be inhibited
[36], bone marrow-derived macrophages (BMDM) were generat-
ed from mice from which the gene encoding cathepsin D was
deleted or from wild-type (WT) littermates. WT and cathepsin
D
2/2 BMDM exhibit comparable lysosomal density and
internalize similar numbers of opsonized pneumococci (Figure
S7A–B). Following pneumococcal infection, cathepsin D
2/2
BMDM failed to demonstrate similar levels of apoptosis under
conditions that caused WT BMDM to undergo dissipation of DYm
(Figure 4A), chromatin condensation and nuclear fragmentation
(Figure 4B). Addition of pepstatin A to WT BMDM infected with
pneumococci phenocopied the cathepsin D
2/2 genotype as far as
the protection of mitochondrial and nuclear integrity were
concerned (Figure 4A–B). However, there was no difference
between untreated WT BMDM, pepstatin-treated BMDM or
cathepsin D
2/2 BMDM at the level of LLA induced by
pneumococcal infection (Figure 4C). These results support the
conclusion that cathepsin D operates downstream of LLA but
upstream of the mitochondrial cell death pathway.
Cathepsin D enhances Mcl-1 ubiquitination
WT BMDM showed a reduction in Mcl-1 protein levels after
pneumococcal infection, as previously described [12]. This effect
was reversed by treatment with pepstatin A or in cathepsin D
2/2
BMDM (Figure 5A). Pepstatin A treatment also reduced the loss of
Mcl-1 following pneumococcal infection in MDMs (data not
shown). Although some proteins involved in apoptosis induction,
such as caspase 8, are direct cathepsin D substrates [27], we found
no evidence Mcl-1 was a cathepsin D substrate, either by in silico
analysis [37] or by searching for Mcl-1 cleavage products in
overexposed immunoblots (data not shown). In contrast, we
observed that pneumococcal infection enhanced the ubiquitina-
tion of Mcl-1 and that cathepsin D inhibition reversed this process
(Figure 5B). Mcl-1 ubiquitination is catalyzed by Mule/ARF-BP1,
an E3 ubiquitin ligase [16]. Heat shock protein Hsp70 reduces
Mule binding to Mcl-1 and Mcl-1 polyubiquitination [38]. Hsp70
expression was induced but there was no evidence of induction of
Mule expression following pneumococcal infection (Figure 5C).
Immunoprecipitation of Mcl-1 demonstrated the expected
downregulation of Mcl-1 with time but indicated there was a
sequential increase in Hsp70 binding (until 12 h) and in Mule
binding (from 12 h) (Figure 6A). The enhancement of the Mcl-1-
Mule interaction, which was triggered by pneumococcal infection,
was demonstrated by immunoprecipitation of either Mcl-1 or
Mule and was reversed by pepstatin A (Figure 6B–C). Conversely,
following pepstatin A treatment the interaction between Hsp70
and Mcl-1 was favored (Figure 6B–C).
Inhibition of cathepsin D decreases bacterial killing
The inhibition of macrophage apoptosis that results from
maintenance of high Mcl-1 levels prevents effective bacterial
killing [12]. We confirmed that caspase inhibition, which reduces
macrophage apoptosis, but does not alter cathepsin D activation
after pneumococcal infection, reduced bacterial killing in differ-
entiated THP-1 cells (Figure S8). Pepstatin A also reduced
bacterial killing. The combination of pepstatin A and caspase
inhibitors did not further suppress the level of apoptosis nor did it
further reduce bacterial killing, suggesting that the antimicrobial
effect of pepstatin A was mediated via inhibition of apoptosis.
Intracellular killing assays were also performed with BMDM from
WT or cathepsin D
2/2 mice. While there was no difference in
bacterial colony counts early post-infection (0–10 h), we detected a
1–1.5 log increase in intracellular bacterial colony counts 16–20 h
after infection in the cathepsin D
2/2 BMDM (Figure 7A). These
time points correspond to the time of induction of mitochondrial
(Figure 1D) and other downstream features of apoptosis in this
model [12], thus confirming a critical role for cathepsin D in the
late increment to bacterial killing provided by macrophage
apoptosis.
A further series of experiments were performed in irradiated
mice that were reconstituted with either cathepsin D
+/+ or
cathepsin D
2/2 bone marrow cells. These mice have normal
numbers of myeloid cells including macrophages and neutrophils
[39] and we also confirmed no baseline differences in numbers of
apoptotic cells in the lung (data not shown). Cathepsin D
2/2
alveolar macrophages from reconstituted mice were normal in
number (Figure S9), yet exhibited absent cathepsin D expression
and reduced apoptosis following pulmonary infection with
pneumococci, as compared to cathepsin D
+/+ controls
(Figure 7B–C). Mice that had undergone bone marrow transplan-
tation with cathepsin D
2/2 bone marrow were significantly
impaired in their capacity to clear low inocula of bacteria from the
lungs (Figure 7D–E), in a model of subclinical infection in which
with Dunnett’s post-test vs. 0 h. (E) AO staining 16 h post-infection of mock infected (Spn 2) or pneumococcal infected (Spn+) differentiated THP-1
cells in the presence (+) or absence (2) of zVADfmk (zVAD) or zFAfmk (zFA), n=3. Spn+ without zVAD/zFA vs. Spn+ with zVAD, p=ns (not significant)
(F) Mock (Spn2) or D39 (Spn+) infected cells were stained with BODIPY FL-Pepstatin A 16 h post-infection and either visualized by microscopy or
analyzed by flow cytometry. The filled histogram is Spn2, black histogram is Spn+, grey is unstained (US). The images and flow histograms are
representative of three independent experiments. Scale bar equal to 5 mm. Quantified flow results are shown below the histogram, n=3 (G) A
Western blot of cytosolic and membrane fractions from mock (Spn2) or D39 (Spn+) infected differentiated THP-1 cells at 16 h post-infection probed
with anti–cathepsin D (CatD) and cathepsin B (CatB). Actin and LAMP-1 were used as loading controls. The blots are representative of three
independent experiments. (H) AO staining of differentiated THP-1 cells 16 h after mock-infection (MI) or exposure to D39 or a pneumolysin-deficient
strain of D39 (PLYSTOP), n=4, *** p,0.001, one-way ANOVA with Tukey’s post-test. In all cases, pooled data are expressed as mean +/2 SEM.
doi:10.1371/journal.ppat.1001262.g001
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PLoS Pathogens | www.plospathogens.org 4 January 2011 | Volume 7 | Issue 1 | e1001262Figure 2. Infection with pneumococci is associated with activation of cathepsin D in differentiated THP-1 cells. (A) A Western blot of
phagolysosomes prepared from differentiated THP-1 cells 14 h after mock infection (MI), or infection with S. pneumoniae strain D39 and isolated
using a discontinuous sucrose gradient was probed for cathepsin D. The blot is representative of three independent infections. (B) Cathepsin D
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survival [8].
Lack of cathepsin D activation results in increased
recruitment of neutrophils
Both cathepsin D
+/+ and cathepsin D
2/2 reconstituted mice
recruited neutrophils following low dose pneumococcal challenge
(Figure 8A–B). This contrasts with mice which have not
undergone bone marrow transplantation, which can control these
levels of bacteria without neutrophil recruitment and in which
impairment of macrophage mediated bacterial clearance results in
enhanced neutrophil recruitment [8]. It is also consistent with the
known effect of bone marrow transplantation to reduce the
effectiveness of pulmonary anti-bacterial host defense [40].
However in two challenge models mice reconstituted with
cathepsin D
2/2 macrophages demonstrated significantly greater
recruitment of neutrophils, a marker of reduced capacity to
control infection and of more extensive disease in these low dose
pneumococcal challenge models [41] than did mice reconstituted
with cathepsin D
+/+ macrophages (Figure 8A–B).
activity was measured in whole cell lysates from mock (Spn2) or D39 (Spn+) infected differentiated THP-1 cells at the designated time points. D39
infected cells showed elevated cathepsin D activity compared to mock infected cells from 8 h, n=4, ***=p,0.001, two-way ANOVA (C) Cathepsin D
activity measured in whole cell lysates at 14 h in mock-infected (MI) cells, or differentiated THP-1 cells infected with the designated Spn strains (D39
or the pneumolysin-deficient strain PLYSTOP), Staph. aureus or latex beads, n=4, ns= not significant *=p,0.05. **=p,0.01, ***=p,0.001 one-way
ANOVA with Tukey’s post-test. (D) Cytosolic pH was measured in mock (Spn2) or D39 (Spn+) infected cells at the designated time points using
SNARF-4F carboxylic acid, acetoxymethyl ester, acetate, n=4, *=p,0.05. **=p,0.01, two-way ANOVA. (E) Cytosolic pH was measured at 14 h in
differentiated THP-1 cells either mock-infected (Spn2) or exposed to D39 pneumococci (Spn+) in the presence (+) or absence (2) of pepstatin A (Pep
A), n=4, *=p,0.05, one-way ANOVA with Dunnett’s post-test vs. MI. In all cases, pooled data are expressed as mean +/2 SEM.
doi:10.1371/journal.ppat.1001262.g002
Figure 3. Cathepsin D activity contributes to apoptosis in the differentiated THP-1 cell line. (A) Differentiated THP-1 cells were stained
with JC-1 16 h after mock-infection (Spn2) or exposure to D39 pneumococci (Spn+) in the presence (+) or absence (2) of pepstatin A or MPC6. Loss
of fluorescence indicates loss of DYm, n=3–5, *=p,0.05, **=p,0.01, two-way ANOVA. (B) A representative Western blot of the cytosolic fractions
of Spn2 or Spn+ cells, 16 h after infection, in cultures incubated with (+) or without (2) pepstatin A (PepA). The blot is representative of four
independent infections. (C) Spn- or Spn+ differentiated THP-1 cells, incubated in the presence (+) or absence (2) of pepstatin A (PepA), were assayed
for caspase activity by fluorimetry 16 h post-infection, n=5, *=p,0.05. (D) Spn2 or Spn+ differentiated THP-1 cells, incubated in the presence (+)o r
absence (2) of pepstatin A or MPC6, were fixed and analyzed for nuclear fragmentation after 20 h culture, n=3–4, *=p,0.05, **=p,0.01, two-way
ANOVA. In all cases, pooled data are expressed as mean +/2 SEM.
doi:10.1371/journal.ppat.1001262.g003
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PLoS Pathogens | www.plospathogens.org 6 January 2011 | Volume 7 | Issue 1 | e1001262Figure 4. Macrophages deficient in cathepsin D show reduced apoptosis. (A) BMDM’s from (WT) or cathepsin D knock-out (KO) mice were
stained with JC-1, 16 h after mock-infection (Spn2) or pneumococcal infection (Spn+) with D39 in the presence (+) or absence (2) of pepstatin A
(PepA), n=7, *=p,0.05, two-way ANOVA. (B) Nuclear fragmentation was detected by DAPI staining, in WT and cathepsin D KO BMDMs, 20 h after
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PLoS Pathogens | www.plospathogens.org 7 January 2011 | Volume 7 | Issue 1 | e1001262The engagement of CXCR2 by CXC chemokines is critical
for neutrophil recruitment in murine models of pneumococcal
pneumonia [42,43,44]. Preliminary data showed cathepsin
D
2/2 BMDM produced higher levels of KC and MIP-2 than
WT BMDM, 16 h after bacterial exposure, consistent with a role
for these chemokines in neutrophil recruitment in other models of
pneumococcal pneumonia (data not shown). To establish whether
the recruited neutrophils were contributing to bacterial clearance
we depleted these with an anti-Ly6G antibody [45]. Mice treated
with this antibody had reduced numbers of neutrophils and WT
mice approximately doubled the bacterial CFU in the lungs after
treatment with anti-Ly6G (Figure 8C), suggesting that at this low
level of infection neutrophils were helping to clear bacteria.
Nevertheless although mice reconstituted with cathepsin D
2/2
bone marrow had significantly higher colony counts in the lung
than those reconstituted with WT marrow, there was no
significant difference in the bacterial colony counts in the lungs
of mice reconstituted with cathepsin D
2/2 after neutrophil
depletion. This suggested that the role of neutrophils in host
defense was redundant and could be compensated for by other
factors, particularly for mice reconstituted with cathepsin D
2/2
bone marrow, during low dose pneumococcal challenge.
In summary, cathepsin D was essential for apoptosis-associated
pneumococcal killing and in the absence of cathepsin D expression
by macrophages there was evidence of impaired bacterial
clearance and markers of more extensive pulmonary disease.
Discussion
During bacterial infection prolonged intracellular killing leads to
macrophage apoptosis, a process which contributes to the late
phase killing of pneumococci [8]. The onset of apoptosis is
determined by the level of the anti-apoptotic protein Mcl-1, a
protein whose short intracellular half-life and regulation by
ubiquitination make it well suited to transducing critical levels of
cell stress into a program of apoptosis [12]. In this study, we
demonstrate that LMP and cathepsin D activation trigger
macrophage apoptosis via Mcl-1 downregulation during pneumo-
coccal infection. Cathepsin D activation stimulates Mcl-1
ubiquitination, correlating with enhanced binding of Mcl-1 to its
ubiquitin ligase, Mule. Cathepsin D is required for host-mediated
macrophage apoptosis and the apoptosis-associated late phase
of bacterial killing. Moreover mice reconstituted with cathepsin
D
2/2 bone marrow have significant impairment in their capacity
to clear pneumococci from the lung and recruit greater numbers
of neutrophils, the central pathologic feature of pneumococcal
pneumonia.
To our knowledge, activation of lysosomal death pathways
during phagolysosomal killing of microorganisms, has not been
previously linked to programs of apoptosis, despite the fact that
LMP and cathepsins have been implicated in multiple cell death
scenarios [20,21,23,25,46,47]. The delayed macrophage death
seen during pneumococcal infection is associated with DYm
dissipation, mitochondrial cytochrome c release, caspase activation
and nuclear fragmentation, which are all hallmarks of classical
apoptosis [12,18,48]. We previously observed that macrophage
apoptosis during pneumococcal killing requires the cholesterol-
dependent cytolysin pneumolysin [48,49]. Since cholesterol-
dependent cytolysins can bind host proteins including pattern
recognition receptors [50,51], and a diverse range of bacteria can
trigger an apoptotic response during bacterial clearance [6], it is
likely that recognition of pneumolysin is part of a more general
innate response which links detection of different bacterial proteins
to LMP, cathepsin D activation and subsequent apoptosis
induction. Cathepsin D may contribute to the recognition of
these bacterial factors by playing a role in their processing. The
cholesterol-dependent cytolysin, listerolysin, is cleaved by cathep-
sin D [52]. However using HIS-tagged pneumolysin, we have so
far been unable to confirm any direct interaction between
pneumolysin and cathepsin D (Bewley and Dockrell unpublished
observations).
Although the molecular mechanisms of LMP in apoptosis are
incompletely characterized, potential causes in our model include
generation of lysosomotropic factors such as ceramide, intracellu-
lar calcium flux or reactive oxygen species [53]. Moreover we
clearly demonstrate LLA and cathepsin D activation occur
upstream of the mitochondrial features of cell death and are not
the result of caspase activation [29]. We have previously shown
that the mitochondrial apoptosis pathway is only activated when
Mcl-1 expression in macrophages falls below maximal levels
during pneumococcal infection [12,48].
We evaluated several cathepsins but observed that cathepsin D
was the major mediator of macrophage apoptosis induced during
pneumococcal infection, though not the only factor as evidenced
by the fact that absence of cathepsin D activation did not
completely abolish apoptosis. Other minor factors are likely to
include other proteases and protease stress is likely to interact with
oxidative and, as we have previously shown, nitrosative stress [48].
In keeping with this, the combination of an antioxidant, inhibition
of inducible nitric oxide synthase and pepstatin A treatment was
particularly efficient in suppressing apoptosis. However, as the
bulk of the inhibition was achieved with each agent alone, we
surmise that all these inhibitors act on a common pathway that
converges at the level of the mitochondria. Cathepsin D is the
most abundant cathepsin in differentiated macrophages[31,54].
The delayed process of cell death we have observed following
pneumococcal infection is differentiation-dependent [10], com-
mensurate with the accumulation of lysosomes and of cathepsin D
in differentiated macrophages [31,55]. We found that pneumo-
coccal infection activated cathepsin D, while phagocytosis of Staph.
aureus failed to do so. The observation that Staph. aureus, which is
readily phagocytosed [32], fails to result in significant activation of
cathepsin D was noteworthy since Staph. aureus is known to survive
in macrophages and prevent macrophage apoptosis by upregulat-
ing Mcl-1 [56].
Cathepsin D was found to be activated within phagolysosomes
and may exert its pro-apoptotic effects either on substrates in the
phagolysosome or in the cytosol after translocation from
phagolysosomes. A fall in cytosolic pH has been identified as a
consequence of bacterial phagocytosis and killing in phagocytes
[33,34]. LLA allows dissociation of procathepsin D from the
phagolysosomal membrane, cathepsin D activation and substrate
cleavage in the phagolysosomal lumen [57]. It has been assumed
that cathepsin D has little activity above pH 6.2 and that its role in
the cytosol would be non-catalytic [58]. However, the pH
dependence of cathepsin D activity is substrate-dependent and
residual activity is detected for some substrates at pH above 6 [59].
Alternatively, as proposed by Conus, acidic pH dependent-activity
mock (Spn2) or D39 pneumococcal (Spn+) infection in the presence (+) or absence (2) of PepA, n=5 per group. (C) Acridine orange staining of
BMDMs 16 h post-infection in the presence (+) or absence (2) of pepstatin A, n=7 per group, *=p,0.05, two-way ANOVA. In all cases, pooled data
are expressed as mean +/2 SEM.
doi:10.1371/journal.ppat.1001262.g004
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PLoS Pathogens | www.plospathogens.org 8 January 2011 | Volume 7 | Issue 1 | e1001262Figure 5. Cathepsin D facilitates Mcl-1 downregulation. (A) A representative Western blot for Mcl-1 from wild-type (WT) and Cathepsin D
knock-out (KO) BMDMs 16 h after mock- (Spn2) or D39 pneumococcal-infection (Spn+), in the presence (+) or absence (2) of pepstatin A. The blot is
representative of four independent experiments. Densitometry was carried out and fold change of Mcl-1 relative to mock-infection was calculated,
n=4*=p,0.05, two-way ANOVA. (B) Spn2 or Spn+ differentiated THP-1 cells were cultured in the presence (+) or absence (2) of pepstatin A (PepA).
At 16 h cells were lysed, ubiquitinated proteins captured, and Western blots carried out probing for total ubiquitinated proteins and for Mcl-1.
Densitometry was carried out and the ratios of Mcl-1 relative to ubiquitin were calculated, n=3, *=p,0.05, one-way ANOVA with Tukey’s post-test.
(C) Spn2 or Spn+ differentiated THP-1 cells were lysed and probed for Hsp70, Mule and actin at the designated times post-infection. The blots are
representative of three experiments and the results summarized by densitometry.
doi:10.1371/journal.ppat.1001262.g005
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[27]. Although, we cannot exclude the possibility that some
intermediary molecule was cleaved by cathepsin D, we found no
evidence that Mcl-1 itself was a substrate. Cathepsin D exerts some
of its functions such as mitogenic stimulation or modulation of
apoptosis by non-catalytic activity [22,58]. Nonetheless, the ability
Figure 6. Cathepsin D activation favors the interaction between Mcl-1 and Mule. (A) Mock-infected (Spn2) or D39 exposed (Spn+)
differentiated THP-1 cells were immunoprecipitated with an anti-Mcl-1 antibody at the designated time period. As controls a separate sample at each
time point was treated with a Mcl-1 peptide. The peptide used was identical to that used to produce the anti-Mcl-1 antibody. This excluded non-
specific binding by the anti-Mcl-1 antibody. Precipitated proteins were blotted for Hsp70, Mule and Mcl-1. Densitometry was carried out and the
ratios of Mule and Hsp70 to the amount of Mcl-1 precipitated was calculated, n=3 *=p,0.05 for comparison of 4 h vs. 16 h, 1-way ANOVA with
Dunnett’s post test. Spn2 or Spn+ differentiated THP-1 cells were cultured in the presence (+) or absence (2) of pepstatin A (PepA) for 16 h and
lysates were immunoprecipitated with anti-Mcl-1 (B) or anti-Mule (C) antibody before being probed for Mule, Hsp70 and Mcl-1. C represents a control
in which mock-infected (MI) cells were immunoprecipitated in the presence of an excess of antigen-specific peptide (Mcl-1) or a non-specific antibody
for the immunoprecipitation of Mule. Densitometry was carried out and the ratios of the immunoblotted proteins to the immunoprecipitated Mcl-1
or Mule were calculated, n=3 ***=p,0.001 for comparison of Spn+ with or without pepstatin A, one-way ANOVA with Tukey’s post-test.
doi:10.1371/journal.ppat.1001262.g006
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as the persistent cathepsin D activity in macrophages exposed to
pneumococci, argues for an important role for cathepsin D acting
as a protease in this model.
Cathepsin D had indirect effects on Mcl-1 regulation via
enhanced ubiquitination of Mcl-1, a major mechanism of Mcl-1
degradation [15], consequent upon increased association of Mcl-1
with its ubiquitin ligase, Mule [16]. The mechanism through
which the Mcl-1/Mule interaction is increased requires further
elucidation, but could include the cathepsin D-dependent
activation of BH3-only proteins, releasing Mcl-1 to interact with
Mule. We found no evidence that cathepsin D activation reduced
levels of Hsp70 protein, a further factor competing for Mcl-1
binding to Mule [38]. Hsp70 is likely to contribute to the
maintenance of macrophage cell viability during the first 12 h
after exposure to pneumococci as it prevents both LMP and Mcl-1
ubiquitination [38,60].
Our demonstration of activation of cathepsin D prior to
induction of a mitochondrial pathway of apoptosis has provided us
with a new tool with which to probe the function of macrophage
apoptosis in host defense against pneumococci. Cathepsin D did
not contribute to bacterial killing prior to apoptosis induction and
pepstatin A did not reduce bacterial killing beyond the level
observed with a caspase inhibitor. Moreover, by using a murine
model in which alveolar macrophages were the only resident cells
that had resistance to apoptosis, we are able to clarify the role of
macrophage apoptosis in a fashion not previously possible with
approaches using caspase inhibition or Mcl-1 over-expression, in
which apoptosis resistance is not selective [8,12]. Using this
approach we now clearly show that macrophage apoptosis is
required for late phase bacterial killing. Resident components of
host defense in the lung control small numbers of bacteria that
penetrate the distal airway. When macrophage function is
subverted by the pathogen [61] or by the sheer size of the
bacterial inoculum [10], activation of apoptosis facilitates bacterial
killing. We cannot at present state the exact basis of this
observation. It could reflect release of factors during the apoptotic
process, such as mitochondrial ROS, that have antimicrobial
effects, a dual role for an effector of apoptosis induction in also
contributing to antimicrobial killing or the possibility that
Figure 7. Cathepsin D in alveolar macrophages contributes to bacterial killing in vitro and in vivo. (A) BMDMs from (WT) or cathepsin D
knock-out (KO) mice were exposed to D39 pneumococci for the indicated time periods. Cells were lysed and intracellular bacteria plated out at the
designated times, n=5 per group, *=p,0.05, two-way ANOVA. (B) A representative Western blot of alveolar macrophages obtained from bronchial
alveolar (BAL) fluid from irradiated mice transplanted with bone marrow from cathepsin D WT or KO mice. (C) The percentage of apoptotic alveolar
macrophages in BAL in mice after adoptive transfer of marrow from WT or KO mice, 24 h after infection with 10
4 type 1 pneumococci, as assessed by
nuclear morphology, n=6–10. The number of surviving bacteria in BAL 14 h (D) and 24 h (E) after infection with 10
4 type 1 pneumococci, n=5–9
**=p,0.01, ***=p,0.001, students t-test. In all cases, pooled data are expressed as mean +/2 SEM.
doi:10.1371/journal.ppat.1001262.g007
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macrophages when these bodies are efferocytosed. This study
confirms that cathepsin D contributes to the antimicrobial effect of
macrophage apoptosis during host defense against pneumococci.
We speculate that the induction of apoptosis allows containment of
bacteria when the phagolysosomal antimicrobial capacity is
‘exhausted’ and prevents bacterial persistence within subcellular
compartments that lack antimicrobial capacity. When the
bactericidal contribution of macrophage apoptosis is over-
whelmed, additional effectors including neutrophils are activated,
and when the inoculum is low, most bacteria are cleared through
redundant mechanisms. Increasing the inoculum overwhelms
these overlapping but redundant elements of host defense and
allows transition to established pneumonia [8]. Macrophage
apoptosis therefore benefits the host at the critical transition
between sub-clinical infection and establishment of pneumonia,
yet has a finite capacity to control infection and can be
overwhelmed by a large bacterial challenge.
In conclusion, we provide evidence that pneumococci stimulate
macrophage LMP. We have found that cathepsin D is a central
effector of apoptosis and that its activation and lysosomal release
functions as a ‘danger signal’ which alerts macrophages to LMP
and the potential translocation of bacteria into the cytosol.
Enhanced ubiquitination of Mcl-1 results in its depletion, thus
initiating the mitochondrial pathway of apoptosis (Figure S10).
Cathepsin D is not only the trigger for apoptotic death of infected
macrophages but is required for the optimal clearance of
pneumococci, at the critical transition between sub-clinical
infection and establishment of pneumonia, supporting an intimate
functional relationship between apoptosis of macrophages and
their bactericidal activity.
Materials and Methods
Bacteria
Type 2 (D39 strain, NCTC 7466) and mutant strain (PLY-
STOP) of S. pneumoniae (Spn) or type 1 (SSISP1/1) for murine
experiments (at the indicated inocula) were grown as described [8].
Staphylococcus aureus (strain SH1000) was grown up in Brain Heart
Infusion (BHI) supplemented with 20% v/v FCS until an
OD610 nm of 0.6 was reached. Prior to infection with S. pneumoniae
strains, thawed aliquots were opsonized in RPMI (Sigma-Aldrich)
containing 10% v/v anti-pneumococcal immune serum [18].
Bacterial numbers were assessed by the surface viable count
method after inoculation on blood agar.
Construction of PLYSTOP
A version of D39, in which toxin production was interrupted by
introduction of a translational stop codon at the 59 end of the gene,
was made by first inserting an extra T base after base 6 in the
pneumolysin gene by site-directed mutagenesis. The altered gene
was then introduced into the chromosome using Janus mutagen-
Figure 8. Absence of functional cathepsin D in macrophages results in increased neutrophil recruitment. Mice were transplanted with
bone marrow from cathepsin D deficient (KO) mice or with bone marrow from wild-type littermates (WT). Mice were instilled with (A) 10
3 colony
forming units of type 1 pneumococci for 24 h or (B) with 10
4 type 1 pneumococci for 14 h and the number of neutrophils in BAL was calculated by
analysis of cytospins. In all experiments, n=3–9 *=p,0.05, students t-test. (C) Mice received bone marrow transplantation as above and WT or KO
mice were instilled with 10
4 type 1 pneumococci in the presence (+) of anti-Ly6G antibody or control antibody (2) to deplete neutrophils, n=6 per
group. In all cases, pooled data are expressed as mean +/2 SEM.
doi:10.1371/journal.ppat.1001262.g008
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as judged by Western blotting and lack of haemolytic activity and
findings were confirmed using a complementation mutant (Figure
S3). The complementation mutation was constructed by transfor-
mation with the shuttle vector pALYI [63] containing the
appropriate DNA insert.
Cells and infection
THP-1 cells were cultured in RPMI plus 10% v/v FCS
(complete media). THP-1 cells were differentiated to a macro-
phage phenotype by treating 0.4610
6 cell/ml with 200 nM PMA
for 3 d, after which the PMA was removed, and the cells left to rest
for a further 5 d after which cell concentration was determined.
These cells have a phenotype similar to monocyte-derived
macrophages (MDM), as evidenced by nuclear to cytoplasmic
ratio, concentration of mitochondria and lysosomes, cell surface
markers, phagocytic capacity, cytokine generation to Toll-like
receptor agonists and susceptibility to apoptosis [28]. Key findings
were also repeated in MDM prepared as described [18]. Murine
BMDMs were obtained by culturing marrow from mice deficient
in either cathepsin D [39], or from the corresponding wild-type
littermates. BMDMs were plated at 0.5610
6 cells/ml for 14 d in
DMEM containing 10% FCS and 10% conditioned L929 media
[8]. After 14 d, representative wells were scraped to determine cell
concentration. All cell types were infected with opsonized
pneumococci or Staph. aureus at a multiplicity of infection of 10,
or mock-infected as described [18]. All pneumococcal strains
where shown to be internalized at similar rates (Figure S1). In
some experiments, cells were incubated with either 100 mM of the
aspartic protease inhibitor pepstatin A, 10 mM of mannose-
pepstatin conjugate (MPC) 6 [64], 2 mM of the cathepsin D
inhibitor diazoacetyl-DL-2-aminohexanoic acid-methyl ester
(DAME) (Bachem), 25 mM of the cathepsin B inhibitor CA-
074Me (Sigma), 50 mM of the cathepsin B and L inhibitor E-64d
(Sigma), 50 mM N-Benzyloxycarbonyl-Val-Ala-Asp(O-Me) fluor-
omethyl ketone zVADfmk (Enzymes Systems Products) as a pan-
caspase inhibitor previously demonstrated to inhibit caspase-
dependent macrophage apoptosis or 50 mM N-benzyloxycarbo-
nyl–Phe-Ala fluoromethyl ketone, (zFAfmk) (Enzyme Systems
Products) as a control for zVADfmk [18], 50 mM trolox
(Calbiochem) as an anti-oxidant and 50 mM 1400 W (Calbio-
chem) as a specific iNOS inhibitor [48]. Cells were treated for 1 h
before infection, and again from 4 h (after washing). Chemokines
were measured in BMDM supernatants using a cytokine ELISA as
previously described [65]
Isolation and identification phagolysosomes
Phagolysosomes were isolated using discontinuous sucrose
gradients [66]. At the designated time-point infected cells were
washed three times in PBS, before being scraped and pelleted.
Cells were then washed and re-suspended in homogenization
buffer (250 mM sucrose, 0.5 mM EGTA, 20 mM Hepes), and
homogenized on ice in a Dounce homogenizer, confirming lysis by
light microscopy. The resulting lysate was cleared of unlysed cells
and nuclei by centrifugation at 4uC at 450 g for 5 min. The
phagolysosomes were then isolated by flotation on a sucrose
gradient (all sucrose solutions w/v in 0.5 mM EGTA, 20 mM
Hepes); the phagolysosome containing supernatant was first
adjusted to 39% sucrose by addition of 65% sucrose solution.
This 39% sucrose supernatant was pipetted into an ultracentrifuge
tube containing 1 ml 65% sucrose overlaid with 2 ml 55%
sucrose. On top of the sample 2 ml steps of 32.5% and 10%
sucrose were added. The resulting five step gradient was spun for
1 h at 4uC at 100,000 g (SW40Ti rotor in a Beckman centrifuge).
Latex bead (Sigma-Aldrich) containing phagolysosomes were
collected from the interface of the 10% and 32.5% solutions.
Bacteria containing phagolysosomes were isolated from the 55%/
65% interface. Latex bead containing phagolysosomes were then
added to PBS and pelleted by spinning for 15 min at 40,000 g.
Bacteria containing phagolysosomes were equilibrated to 11%
sucrose (using homogenization buffer without sucrose), and
overlaid on a 15% Ficoll cushion (in 5% sucrose, 0.5 mM EGTA,
20 mM Hepes) and spun for 20 min at 18,000 g. The resulting
pellet was then re-suspended in homogenization buffer and spun
for 10 min at 18,000 g. For positive identification of phagolyso-
somes on the initial gradient, after the first centrifugation step the
sucrose gradient was aliquoted into fractions and the protein in
each aliquot TCA precipitated. Each fraction was probed for
proteins known to be associated with phagolysosomes and
visualised by Western blot. Each fraction was probed with anti-
pneumolysin (1:1000, provided by T. Mitchell), cathepsin D
(1:1000, R&D systems), rab5 (mouse monoclonal, 1:1000, BD
Bioscience), rab7 (mouse monoclonal, 1:1000, Abcam), or LAMP-
1 (mouse monoclonal, 1:1000, BD Bioscience). Each fraction was
also probed for the Golgi protein GM130 (mouse monoclonal
1:1000, BD bioscience).
SDS-PAGE and Western immunoblotting
Whole cell extracts and cytosolic fractions were isolated as
previously described [48]. Blots were incubated overnight at 4uC
with antibodies against either human Mcl-1 (rabbit polyclonal SC-
19, 1:1000; Santa Cruz Biotechnology Inc, recognizing full length
Mcl-1, 40 kDa and ubiquitinated Mcl-1, .40 kDa), murine Mcl-1
(1:1000; Rockland), cytochrome c (mouse monoclonal, 1:1000; BD
Biosciences), cathepsin D (goat polyclonal, 1:1000; R&D Systems,
recognizing pro-cathepsin D (52 kDa), an active intermediate
(48 kDa) and the heavy chain of active cathepsin D (34 kDa)),
cathepsin B (mouse monoclonal, 1:1000, Abcam), actin (rabbit
polyclonal 1:5000; Sigma-Aldrich), Mule/ARF-BP1 (1:500, Ab-
cam), Hsp70 (rabbit polyclonal, 1:1000; Abcam), LAMP-1 (mouse
monoclonal, 1:1000; BD Bioscience) or ubiquitin (Pierce Scientific
1:500). Protein detection was with horseradish peroxidase
conjugated secondary antibodies (1:2000; Dako) and ECL
(Amersham Pharmacia). Bands were quantified using Image J
1.32 software (NIH). In Western blot experiments fold change
from mock-infected or earliest time-point was calculated and
normalized to the fold change in actin [12]. In co-immunopre-
cipitation experiments the ratio of the blotted proteins to the
precipitated protein was calculated.
Immunoprecipitations
For IPs, cells were lysed in 2% 3-[(3-cholamidopropyl)
dimethylammonio]-1-propane sulfonate hydrate (CHAPS) lysis
buffer (20 mM Tris-HCl (pH 7.4), 137 mM NaCl, 2 mM EDTA,
2% CHAPS) containing phosphatase and protease inhibitors
(2 mg/ml each of pepstatin, leupeptin and aprotinin) and
phosphatase inhibitors (50 mM sodium fluoride and 1 mM
sodium vanadate) for 30 min on ice. The lysates were incubated
overnight at 4uC on a rotator with 2 mg of anti-Mcl-1 (sc-819:
Santa Cruz) antibody or anti-Mule (Abcam). Immunoprecipitates
were collected by the addition of 10 ml of washed protein A
agarose beads (EZview Affinity Gel; Sigma-Aldrich) and incuba-
tion for 1 h at 4uC on a rotator. The beads were collected by
centrifugation and washed three times with lysis buffer. Finally, the
pelleted beads were resuspended in sodium dodecyl sulfate (SDS)
sample buffer and heated at 95uC for analysis by SDS-
polyacrylamide gel electrophoresis, loading equal concentrations
of protein from the original lysate, and Western blotting with the
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performing Mcl-1 IPs in the presence of an excess of the Mcl-1
peptide, which had been used to generate the antibody (sc-819P:
Santa Cruz Biotechnology) and the mule IPs with a non-specific
antibody (rabbit IgG, Sigma).
Lysosomal immunocytochemistry
BMDM were fixed for 15 min in 2% paraformaldehyde,
permeabilized with 0.2% Triton-X for 5 min, before being stained
using standard protocols for indirect immunofluorescence. LAMP-
1 was visualized with anti-LAMP-1 antibody (1:100, BD
Bioscience) and rabbit anti-mouse FITC (DAKO). Slides were
counterstained with DAPI (blue) to show nuclear localization.
Analysis of loss of lysosomal acidification
To detect loss of lysosomal acidification, cells were stained with
the azurophilic dye acridine orange (Sigma-Aldrich). At designated
time-points, cells were washed three times with PBS before being
incubated at 37uC in RPMI containing 5 mM acridine orange for
15 min. The cells were then washed and re-suspended in ice cold
PBS and analyzed by flow cytometry.
Cathepsin D localization and activation
To visualize cathepsin D, macrophages were loaded with 1 mM
pepstatin A-BODIPY FL conjugate (Invitrogen) in complete
media, for 30 min at 37uC. Pepstatin A-BODIPY FL binds
cathepsin D at acidic pH [30]. After staining, cells were washed in
PBS and incubated at 37uC for a further 1 h in complete media.
Live cells were imaged on a Leica AF6000LX inverted microscope
with a DFC 350FX RZ camera and LAS AF Lite software version
1.8, at 37uC, using a 636lens, numerical aperture 0.7. Cathepsin
D activity was measured using a fluorometric cathepsin D activity
assay kit (Abcam) in accordance with the manufacturer’s
instructions. Fluorescence was measured on a Packard Bioscience
Fusion microplate analyzer. Cathepsin D activity in each sample
was expressed as percentage of a comparative sample that had
been treated with 500 mM pepstatin A to act as a negative control.
Ubiquitin pull-down assay
Ubiquitinated proteins were isolated using an enrichment kit for
ubiquitin (Pierce Scientific) according to the manufacturer’s
instructions. Levels of ubiquitin were analyzed by Western blot,
probing for ubiquitin and other proteins of interest.
Caspase activity assay
Cellular caspase activity was measured using the Caspase-Glo
3/7 Assay (Promega) according to the manufacturer’s instructions.
Luminescence was measured on a Packard Bioscience Fusion
microplate analyzer.
Measurement of cytosolic pH
Intracellular pH was measured using the dye SNARF-4F
carboxylic acid, acetoxymethyl ester acetate (Carboxy-SNARF-
4F-AM) (Molecular Probes). 0.5610
6 cells per sample were pelleted
and re-suspended in HEPES-buffered medium containing 10 mM
carboxy-SNARF-4F-AM, and incubated at 37uC for 30 min. After
incubation, cells were washed and re-suspended in fresh medium.
The cells were then analyzed by flow cytometry, with the
intracellular pH values being determined by measuring the ratio
of fluorescent emissions at 575 nm and 635 nm. A standard curve
was generated by calibration of the fluorescence ratio in buffers of
different ionic strength, containing the proton ionophore nigericin,
to convert this fluorescence ratio to intracellular pH.
Detection of apoptosis
To detect loss of Dym, at the required time-points, cells were
stained with 10 mM 5,59, 6,69-tetrachloro-1, 19, 3,39 tetraethyl-
benzimidazolocarbocyanine iodide (JC-1; Sigma-Aldrich) and
analyzed by flow cytometry. Loss of Dym was demonstrated by
a loss of fluorescence on the FL-2 channel as previously described
[12]. Nuclear fragmentation was detected by 4969-diamidino-2-
phenylindole (DAPI, Molecular Probes) staining as described
previously. Briefly, three hundred cells per coverslip, from at least
two fields of view from the edge were counted in duplicate samples
by blinded reviewers [8].
In-vitro killing assay
Assessment of intracellular killing was carried out at designated
times as before [48]. For assessment of bacterial killing, cells were
infected and at 4 h washed three times in PBS before being
incubated for 30 min at 37uC in RPMI containing 40 Mu
penicillin and 20 mg/ml gentamicin, washed and incubated with
0.75 mg/ml vancomycin (Sigma) to kill extracellular bacteria. At
the designated time cells were then washed three times in PBS
before being lysed in 250 ml 2% saponin for 12 min. The lysate
was made to 1 ml in PBS, and a viable count performed. Wells
were lysed in triplicate for each time point.
Hemolytic assay
Strains of bacteria were diluted to give equivalent OD600
before being pelleted, resuspended in PBS, and lysed by
sonication. Red blood cells were isolated by centrifugation from
defribrinated sheep blood (TCS Biosciences), washed three times
in PBS and resuspended, to give a 2% solution. 50 ml of this
solution was added to 50 ml PBS and placed in a round-bottomed
plate. 50 ml of bacterial lysate was added per well, and the plate
incubated at 37uC for 1 h. Another 50 ml PBS was added, and the
plate centrifuged at 10006g. Supernatants were analysed for the
release of hemaglobin by measuring the OD at 490 nm.
Bone marrow transfer and in vivo infection
Recipient mice were 6 week old C57BL/6J female mice
(Charles River), maintained on acidified water in individual
ventilated cages and irradiated with 2 doses of 550 rads separated
by 4 h. Donor bone marrow, was obtained from cathepsin D
deficient mice, or wild-type littermates, that had been backcrossed
for 10 generations onto a C57BL/6J background. Bone marrow
was isolated as described previously [39] and resuspended in
HBSS at approximately 1610
7 cells/ml. 4 h after the second dose
of radiation, 200 ml of the bone marrow cell suspension was
injected into each recipient mouse via the tail vein. Bone marrow
transplantation was confirmed by reconstitution of neutrophil
numbers in the peripheral blood and by demonstrating alveolar
macrophage expression, or absence of expression, of cathepsin D,
as appropriate depending on the donor’s genotype. The mice were
maintained in individual ventilated cages with free access to
autoclaved food and acidified water for 3 months before
intratracheal instillation with 1610
3 or 1610
4 colony forming
units of murine passaged type 1 S. pneumoniae as described
previously [8]. Mice were killed 14–24 h after infection, and
bronchoalveolar lavage and lungs collected. Bacterial numbers in
the lung and alveolar macrophage apoptosis were assessed as
previously described [8]. Neutrophil recruitment was assessed by
hemocytometer counts and analysis of cytospin preparations [8].
To deplete neutrophils mice were injected ip with 100 mg anti-Ly-
6G antibody (clone RB6-8C5, eBioscience) or 100 mg rat IgG
(eBioscience) 24 hours prior to infection with S. pneumoniae [45].
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of 71.4%. All experiments were performed in accordance with the
UK Animals Act, authorised under a UK Home Office Licence,
and approved by the animal project review committee of the
University of Sheffield.
Statistical analysis
Pooled data are expressed as mean and SEM. The indicated
statistical tests were performed using Prism 4.0 software (Graph-
pad Inc). Significance was defined as P,0.05.
Supporting Information
Figure S1 The number of bacteria internalized is equivalent in
differentiated THP-1 cells, when exposed to pneumolysin
sufficient or deficient strains of pneumococci. Differentiated
THP-1 cells were infected with the designated strain of Spn
(D39 or a D39 mutant which lacks pneumolysin PLYSTOP). At
4 h post-infection internalized bacteria were stained and counted,
(n=3). Internalization of D39 was also measured in cells that had
been treated with pepstatin A (+PepA) as in materials and
methods.
Found at: doi:10.1371/journal.ppat.1001262.s001 (0.26 MB TIF)
Figure S2 Phagolysosome isolation. Differentiated THP-1 cells
were infected with D39. Six hours post-infection the phagolyso-
somes were purified on a discontinuous sucrose gradient by
ultracentrifugation. Fractions from throughout the gradient were
taken and separated by SDS-PAGE before being probed for
pneumolysin and for the lysosomal markers pneumolysin,
cathepsin D, rab5, rab7 or LAMP1. The Golgi protein GM130
was also probed for as a control for organelle contamination.
Found at: doi:10.1371/journal.ppat.1001262.s002 (2.28 MB TIF)
Figure S3 Validation that a pneumolysin complementation
mutant restores the phenotype of the parental strain. Acridine
orange (A) and JC-1 (B) staining of differentiated THP-1 cells 16 h
post-infection. Cells were mock-infected (MI) or infected with D39
pneumococci, a strain overexpressing pneumolysin (SH3), a strain
deficient in pneumolysin (PLYSTOP) or a complemented strain
(SH3PLYSTOP). Representative histograms from one infection
and graphs summarizing loss of lysosomal acidification (LLA) and
inner mitochondrial transmembrane potential (Dym) from four
independent infections are shown, n=4. (C) A hemolytic assay
measuring optical density (OD) at 490 nm performed on bacterial
lysates of the designated strain of pneumococci, n=3. (D)
Cathepsin D activity measured in differentiated THP-1 cell lysates
14 h post-infection. Cells were mock-infected (MI), or infected
with the designated strain of pneumococci in the presence (+PepA)
or absence of pepstatin A, n=3. In all graphs *=p,0.05,
**=p,0.01, one-way ANOVA with Tukey’s post-test.
Found at: doi:10.1371/journal.ppat.1001262.s003 (1.16 MB TIF)
Figure S4 Cathepsin D, but not other cathepsins, plays a role in
apoptosis induction. (A) Differentiated THP-1 cells were mock-
infected (Spn-) or infected with D39 pneumococci (Spn+) infected
in the presence (+) or absence (2) of inhibitors to cathepsin D
(Pepstatin A; PepA), cathepsin B (CA-074Me) or cathepsins B and
L (E-64d), and stained with JC-1 at 16 h post-infection, n=3. (B)
Spn2 or Spn+ differentiated THP-1 cells were infected in the
presence (+) or absence (2) of diazoacetyl-DL-2-aminohexanoic
acid-methyl ester (DAME), and assayed for nuclear fragmentation
20 h after infection, n=4. For both graphs *=p,0.05, two-way
ANOVA. In all cases, pooled data are expressed as mean +/2
SEM.
Found at: doi:10.1371/journal.ppat.1001262.s004 (0.50 MB TIF)
Figure S5 Reactive oxygen and nitrogen species contribute to
macrophage apoptosis. Mock-infected (Spn2) or D39 infected
(Spn+) differentiated THP-1 cells were incubated in the presence
of (+) or absence of (2) pepstatin A, the specific iNOS inhibitor
1400W, or the antioxidant trolox, either individually, or in
combination. Cells were fixed and analyzed for nuclear fragmen-
tation 20 h post-infection, n=4, *=p,0.05, **=p,0.01,
***=p,0.001, one-way ANOVA with Tukey’s post-test.
Found at: doi:10.1371/journal.ppat.1001262.s005 (0.22 MB TIF)
Figure S6 Results in monocyte-derived macrophages (MDM)
replicate those seen in differentiated THP-1 cells. (A) A Western
blot for the active (mature heavy chain) form of cathepsin D (Cat
D) performed with whole cell lysates from mock-infected (Spn2)
or D39 infected (Spn+) 16 h post-infection. The blot is
representative of three independent infections in three separate
donors. Acridine orange (B) and JC-1 staining (C) measuring loss
of lysosomal acidification (LLA) and inner mitochondrial trans-
membrane potential (Dym) respectively, at 16 h post-infection, in
cells mock-infected (Spn2) or infected with D39 (Spn +) in the
presence (+) or absence (2) of pepstatin A (PepA), n=4. (D)
Nuclear fragmentation analysed 20 h post-infection, in Spn2 or
Spn+ MDM in the presence (+) or absence (2) of pepstatin A
(PepA), n=3. In all graphs *=p,0.05, one-way ANOVA with
Tukey’s post-test.
Found at: doi:10.1371/journal.ppat.1001262.s006 (0.56 MB TIF)
Figure S7 Cathepsin D deficient BMDMs exhibit similar
lysosomal density and phagocytic function to wild-type (WT)
BMDMs. (A) Immunohistochemistry was performed on WT and
cathepsin D knockout BMDMs stained with the lysosomal marker
LAMP1 (green). Slides were counterstained with DAPI (blue) to
show nuclear localization. (B) WT and cathepsin D knock-out
(KO) BMDMs were infected with FITC-labelled opsonized
pneumococci. At 4 h post-infection the number of internalized
bacteria was determined, (n=3).
Found at: doi:10.1371/journal.ppat.1001262.s007 (2.11 MB TIF)
Figure S8 Cathepsin D contributes to bacterial killing through
the initiation of apoptosis. (A) Differentiated THP-1 cells were
mock-infected (Spn2) or exposed to D39 pneumococci (Spn+), in
the presence (+) or absence (2) of zVADfmk (zVAD), zFAfmk
(zFA) or pepstatin A (PepA). (A) Nuclear fragmentation in Spn2
or Spn+ differentiated THP-1 cells 20 h post-infection, n=3. (B)
Cathepsin D activity measured in Spn2 or Spn+ differentiated
THP-1 cell lysates 14 h post-infection, n=3. (C) Intracellular
colony forming units (CFU) in Spn+ differentiated THP-1 cell
lysates 16 h post-infection, in the presence or absence of the
indicated inhibitors, n=3. In all graphs ns = not significant,
*=p,0.05, one-way ANOVA with Tukey’s post-test.
Found at: doi:10.1371/journal.ppat.1001262.s008 (0.36 MB TIF)
Figure S9 Mice reconstituted with cathepsin D deficient bone
marrow have similar numbers of alveolar macrophages to those
reconstituted with wild-type bone marrow. Irradiated mice were
reconstituted with either wild type (WT) or cathepsin D knock-out
(CatD KO) bone marrow. The number of macrophages present in
the bronchial alveolar fluid was determined by cytospin counts
three months after transplantation, n=6. There were no
significant differences between groups. In all cases, pooled data
are expressed as mean +/2 SEM.
Found at: doi:10.1371/journal.ppat.1001262.s009 (0.18 MB TIF)
Figure S10 A model for the role of cathepsin D in macrophage
apoptosis. After internalization of S. pneumoniae into the
phagolysosome, pneumolysin (PLY) activates cathepsin D (Cat
D). Lysosomal membrane permeabilization results in translocation
Macrophage Cathepsin D in Pneumococcal Infection
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binding of Mule to Mcl-1 and thus an increase in proteasomal
degradation of Mcl-1 via ubiquitination. This leads to an increase
in the turn-over of Mcl-1, which allows Bax and Bak activation,
mitochondria outer membrane permeabilization and the initiation
of downstream apoptotic features.
Found at: doi:10.1371/journal.ppat.1001262.s010 (1.64 MB TIF)
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